MEVA Cognitive Wellness Platform Study for Adults
MEVA
Phase 1 Validation Study of the MEVA Cognitive Wellness Platform
2 other identifiers
observational
100
0 countries
N/A
Brief Summary
The goal of this observational study is to evaluate the reliability, usability, and feasibility of the MEVA Cognitive Wellness Platform in community-dwelling adults aged 55 to 75. The main questions it aims to answer are: How consistent is the MEVA Global Cognitive Index when participants complete the MEVA activities again approximately 14 days later? How usable and acceptable is the MEVA platform for older adults in community settings? What completion rates, data quality patterns, and participant feedback are observed during use of the platform? Participants will: Complete a baseline study visit lasting approximately 45 to 60 minutes Complete a 7-activity digital cognitive wellness battery Answer questionnaires about usability, technology acceptance, and wellness experience Complete the Saint Louis University Mental Status (SLUMS) examination as an exploratory comparison measure If selected for the retest group, return approximately 14 days later to complete the MEVA activities again MEVA is being evaluated as a cognitive wellness platform. It is not intended to diagnose, treat, prevent, screen for, or monitor any disease or medical condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
May 20, 2026
May 1, 2026
3 months
May 12, 2026
May 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Test-retest reliability of the MEVA Global Cognitive Index
Intraclass correlation coefficient (ICC) for the MEVA Global Cognitive Index between baseline and retest visits. The Global Cognitive Index is a composite wellness metric derived from performance across four cognitive wellness domains: visuospatial ability, processing speed, language, and executive function. Reliability will be estimated using ICC(3,1), two-way mixed effects model, absolute agreement, single measurement. Success criterion: ICC point estimate ≥ 0.75 with lower 95% confidence interval bound ≥ 0.60.
Baseline (Visit 1) and retest approximately 14 days later (Visit 2, allowed window 11-17 days)
Secondary Outcomes (6)
Task completion rate
Baseline and 14-day retest (11-17 day window)
Exploratory convergent validity with SLUMS
Baseline (Visit 1)
Exploratory age-stratified score distributions
Baseline (Visit 1)
Test-Retest Reliability of Individual MEVA Digital Activity Scores
Baseline (Visit 1) and retest approximately 14 days later (Visit 2, allowed window 11-17 days)
Test-Retest Reliability of MEVA Domain Composite Scores
Baseline and 14-day retest (11-17 day window)
- +1 more secondary outcomes
Study Arms (1)
MEVA Study Cohort
Community-dwelling adults aged 55 to 75 who complete the MEVA digital cognitive wellness battery at baseline. A subset of participants will complete the MEVA battery again approximately 14 days later to assess test-retest reliability.
Interventions
Participants complete an activity digital cognitive wellness battery designed to evaluate reliability, usability, feasibility, participant experience, and data quality. MEVA is being evaluated as a general wellness platform and is not used to diagnose, treat, prevent, screen for, or monitor any disease or medical condition.
Eligibility Criteria
Community-dwelling adults aged 55 to 75 years who are generally healthy or have stable chronic conditions and are interested in cognitive wellness research. Participants are recruited through community-based outreach, including senior centers, libraries, faith-based organizations, wellness programs, and word of mouth. Recruitment is designed to support demographic and socioeconomic diversity.
You may qualify if:
- Adults aged 55 to 75 years
- Community-dwelling (living independently in the community)
- English fluency sufficient for informed consent, task instructions, and questionnaires
- Able to provide informed consent using teach-back method
- Able to use a computer or tablet for simple tap or drag interactions
- Functional vision sufficient for on-screen tasks with usual corrective lenses
- Functional hearing sufficient for spoken instructions with or without hearing aids
- Interest in cognitive wellness and personal well-being
- Available for baseline visit and possible retest visit approximately 14 days later
- Transportation to study site or ability to participate remotely if permitted by protocol
- Assistive devices and accommodations are permitted
You may not qualify if:
- Severe visual impairment preventing completion of digital tasks
- Severe motor impairment preventing interaction with tablet or web application
- Known diagnosis of moderate or severe dementia, or inability to comprehend consent and task instructions
- Current participation in another cognitive training or technology intervention study likely to confound outcomes
- Recent hospitalization, emergency room visit, or acute exacerbation of a medical or psychiatric condition within the past 30 days that would impede study participation
- Current substance use disorder likely to interfere with study adherence or completion
- Recent intensive use of a similar structured cognitive wellness or brain training application
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mentage LLClead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dwight Bellingham, MD
Bellingham Family Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2026
First Posted
May 19, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
May 20, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to small sample size (target n=40 complete test-retest pairs), participant privacy considerations, and proprietary platform development. Aggregate results will be reported in scientific publications and regulatory summaries.